Hari Kamaraju
About Hari Kamaraju
Hari Kamaraju serves as the Executive Director at Sana Biotechnology, Inc., bringing over 12 years of experience in cell therapy and advanced therapies manufacturing. He has held various leadership roles at prominent organizations, including Johnson & Johnson and Reliance Industries Limited, and possesses advanced degrees in technology and business.
Work at Sana Biotechnology
Hari Kamaraju serves as the Executive Director at Sana Biotechnology, Inc. since 2022. His role involves overseeing various aspects of the company's operations in the San Francisco Bay Area. His extensive background in cell therapy contributes to the strategic direction of the organization, particularly in the development of innovative therapies.
Education and Expertise
Hari Kamaraju holds a Bachelor of Technology (B.Tech.) from Jawaharlal Nehru Technological University. He furthered his education with a Master of Science (MS) from Villanova University and a Master of Business Administration (MBA) from The Wharton School. His academic background supports his expertise in cell therapy and advanced manufacturing processes.
Background in Cell Therapy
With 12 years of experience in cell therapy, Hari Kamaraju has worked across various phases of process development and regulatory filings. His career includes significant roles at Johnson & Johnson, where he contributed to the development and scaling of novel non-platform processes like CAR-T, and was involved in the design and start-up of CAR-T facilities.
Previous Roles and Experience
Prior to his current position, Hari Kamaraju held multiple roles at Johnson & Johnson, including Sr. Manager and Director of Advanced Therapies Manufacturing Excellence. He also worked at Reliance Industries Limited and Dr. Reddy's Laboratories early in his career. His experience includes evaluating new technologies and presenting strategies to senior management.
Achievements in Manufacturing Excellence
Throughout his career, Hari Kamaraju has been responsible for technology transfer to external manufacturing partners. His leadership in manufacturing excellence has been demonstrated through his roles at Johnson & Johnson, where he focused on advanced therapies and process development, contributing to the overall efficiency and effectiveness of manufacturing operations.